Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Dapefy S 5mg/50mg Tablet
Manufacturer/Marketed By : SUN PHARMACEUTICAL INDUSTRIES LTD
$2.89 $2.32
Dapefy S 5mg/50mg tablets contains an active component as Dapagliflozin and sitagliptin. These are two different medications used to treat type 2 diabetes mellitus. They work through different mechanisms and...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
DAPAGLIFLOZIN,SITAGLIPTIN
Active Pharmaceutical Ingredient
Dapefy S 5mg/50mg Tablet
$2.89
$2.32
Dapefy S 5mg/50mg tablets contains an active component as Dapagliflozin and sitagliptin. These are two different medications used to treat type 2 diabetes mellitus. They work through different mechanisms and can be combined to help control blood sugar levels in certain patients. Dapagliflozin is a medication belonging to the class of drugs called sodium-glucose cotransporter 2 (SGLT2) inhibitors. This helps to lower blood glucose levels and reduce the overall blood sugar burden in the body. Sitagliptin is a medication is classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor. It regulates the blood glucose levels by stimulating insulin release and reducing glucagon production, a hormone that raises blood sugar. This medication can be particularly beneficial for overweight or obese individuals with type 2 diabetes, as it can help achieve and maintain healthy body weight. It is indicated for treating type 2 diabetes only and should not be used to treat type 1 diabetes. Individuals with known hypersensitivity or allergy to Dapefy S 5mg/50mg tablets or other components of these medications should not take them. It is primarily eliminated through the kidneys. Therefore, individuals with severe renal impairment or end-stage renal disease should not use this medication. During periods of illness, surgery, or other stressful situations, there may be an increased risk of developing ketoacidosis, particularly in those taking dapagliflozin. Temporary discontinuation of this medication during such events may be necessary. There is limited data on the safety of Dapefy S 5mg/50mg tablets during pregnancy and breastfeeding. Pregnant or breastfeeding individuals should consult their healthcare provider before using this medication.
Active Pharmaceutical Ingredient
Uses
• Type 2 diabetes mellitus
• Obese individuals with type 2 diabetes
Benefits
The Dapefy S 5mg/50mg tablets in the treatment of type 2 diabetes provides a dual therapeutic effect by lowering blood glucose levels through different mechanisms: dapagliflozin reduces glucose reabsorption in the kidneys, leading to increased urinary excretion, while sitagliptin enhances insulin secretion and reduces glucagon production. This approach improves glycemic control, reduces the risk of hypoglycemia, and may offer cardiovascular and renal benefits.
Side Effects
Dapefy S 5mg/50mg tablets cause some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Genital yeast infections (vaginal or penile)
• Urinary tract infections (UTIs)
• Increased urination
• Thirst
• Dehydration
• Low blood pressure (hypotension)
• Dizziness or lightheadedness
• Increased levels of cholesterol and blood fats (hyperlipidemia)
Common Side Effects
• Upper respiratory tract infections (colds, sore throat)
• Headache
• Stomach upset or nausea
• Diarrhea
• Hypoglycemia (low blood sugar)
• Joint pain (arthralgia)
How To Use
Dapefy S 5mg/50mg tablets can be administered orally in tablet form. The specific usage instructions may vary depending on the condition being treated and the form of the medication. Oral tablets are typically taken with water, as directed by the healthcare provider.
Safety Advice
• Breast Feeding: The safety of Dapefy S 5mg/50mg tablets during breastfeeding has not been well studied, and limited information is available regarding its excretion into breast milk. As a result, it is recommended to exercise caution when using it while breastfeeding.
• Alcohol: Dapefy S 5mg/50mg tablets with alcohol can increase the risk of certain side effects and adverse reactions. It is generally recommended to avoid or limit alcohol consumption while taking these medications.
• Liver: If you have a liver impairment or concerns about the safety of using Dapefy S 5mg/50mg tablets, discuss these with your healthcare provider. They can provide personalized guidance and ensure the most appropriate treatment plan for your medical condition.
• Lungs: Individuals with pre-existing lung conditions must inform their healthcare provider about their medical history before starting any new medication.
• Driving: Dapefy S 5mg/50mg tablets can cause side effects that may impair driving abilities in some individuals. Therefore, caution is advised when operating a vehicle or performing any tasks that require alertness and concentration while taking these medications.
• Pregnancy: The safety of Dapefy S 5mg/50mg tablets during pregnancy has not been extensively studied, and limited information is available regarding its use in pregnant women. So it is advisable to consult a healthcare provider before using it.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.